Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN9A | Q15858 | 8/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.41 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | TACR2 | P21452 | 1/20 | 0.40 |
| ▸ | CNR2 | P34972 | 1/20 | 0.40 |
| ▸ | STAT3 | P40763 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2356486 | 0.91 | SCN9A (0.45) | SCN9AALDH1A1ITGB3ITGA2BTACR2 | |
| SCHEMBL2171096 | 0.87 | SCN9A (0.51) | SCN9AALDH1A1KMT2AMEN1 | |
| SCHEMBL2169958 | 0.86 | SCN9A (0.47) | SCN9AALDH1A1KMT2ALMNAMEN1 | |
| SCHEMBL2170108 | 0.85 | LMNA (0.52) | SCN9AALDH1A1KMT2ALMNAMEN1 | |
| SCHEMBL2171705 | 0.85 | MEN1 (0.60) | ALDH1A1KMT2ALMNAMEN1 | |
| SCHEMBL2170398 | 0.84 | ALDH1A1 (0.51) | SCN9AALDH1A1CNR2 | |
| SCHEMBL2171851 | 0.84 | KMT2A (0.53) | SCN9AALDH1A1KMT2ATACR2 | |
| SCHEMBL2169808 | 0.84 | SCN9A (0.48) | SCN9AALDH1A1TACR2 | |
| SCHEMBL2171621 | 0.84 | QRFPR (0.50) | SCN9AALDH1A1ITGB3ITGA2B | |
| SCHEMBL2170811 | 0.83 | MAPT (0.54) | SCN9AALDH1A1KMT2ALMNAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2346821-A1 | SPHINGOSINE-1-PHOSPHATE RECEPTOR ANTAGONISTS | Exelixis, Inc. (US) | 2011-07-27 | — | — | EP | disclosed |